The global Vaginitis Therapeutics Indsutry is experiencing robust growth, driven by the increasing global prevalence of various vaginal infections, rising awareness regarding women's health and hygiene, and advancements in diagnostic and treatment options. The market provides pharmaceutical interventions for conditions like bacterial vaginosis, vulvovaginal candidiasis (yeast infectio... https://www.databridgemarketresearch.com/reports/global-vaginitis-therapeutics-market